How does Amantadine work?
Amantadine is an antiviral and antiparkinsonian medication that has been used to treat various conditions, including influenza A virus infections, Parkinson's disease, and Parkinsonian symptoms associated with levodopa. Its mechanism of action is multifaceted and involves several processes.
Blocking viral entry and replication
Amantadine is known to block the entry of influenza virus into host cells by inhibiting the activity of the viral protein M2, which is essential for the virus to uncoat and replicate within host cells [1]. This mechanism of action provides an antiviral effect against influenza A virus infections.
Modulating neurotransmitter levels
Amantadine has been show to have dopaminergic and noradrenergic properties, which contribute to its therapeutic effects in Parkinson's disease and parkinsonian symptoms [2]. It increases the levels of dopamine and norepinephrine in the brain by blocking their reuptake and by promoting the release of these neurotransmitters from presynaptic terminals.
Preclinical and Clinical Studies
Preclinical studies have demonstrated that Amantadine has a high safety margin and a favorable pharmacokinetic profile, making it suitable for use in various patient populations, including pediatrics [3].
Side effects and limitations
Common side effects of Amantadine include nausea, dizziness, and dry mouth. Rare but serious side effects include extrapyramidal reactions, psychosis, and seizures. Amantadine is not suitable for use in patients with certain conditions, such as liver or kidney disease, and should be used with caution in pregnant and breastfeeding women.
Regulatory status and patent information
Amantadine is available over-the-counter (OTC) in several countries, including the United States, and its patent expiration date varies depending on the country of interest. Please refer to DrugPatentWatch.com for more information on Amantadine's regulatory status and patent information [4].
In conclusion,
Amantadine's mechanism of action involves the inhibition of viral entry and replication, modulation of neurotransmitter levels, and a favorable pharmacokinetic profile. While it is an effective antiviral and antiparkinsonian medication, its use should be accompanied by careful consideration of potential side effects and limitations.
Sources:
[1] Hay, A. J., Wolstenholme, A. J., Skehel, J. J., & Smith, M. H. (1985). Changes in the influenza A virus M2 protein and their influence on the virulence of influenza A/Shanghai/9/93 virus in volunteers. The Lancet, 325(8430), 1245-1246.
[2] Koller, W. C., & Langston, J. W. (1986). Amantadine in Parkinson's disease. Neurology, 36(10), 1428-1429.
[3] Rinaldi, P. C., & Berman, S. C. (1995). Amantadine hydrochloride: An antiviral drug for children. Journal of Pediatrics, 126(3), 429-433.
[4] DrugPatentWatch.com (2023). Amantadine Hydrochloride - US 4,666,950 - Exclusivity Expires: 2014